Aura Biotechnologies Profile
Key Indicators
- Authorised Capital ₹ 1.20 Cr
as on 17-07-2024
- Paid Up Capital ₹ 1.20 Cr
as on 17-07-2024
- Company Age 10 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 Cr
as on 17-07-2024
- Satisfied Charges ₹ 3.63 M
as on 17-07-2024
- Revenue -67.09%
(FY 2023)
- Profit -49.84%
(FY 2023)
- Ebitda -96.58%
(FY 2023)
- Net Worth 19.89%
(FY 2023)
- Total Assets 4.02%
(FY 2023)
About Aura Biotechnologies
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.20 Cr and a paid-up capital of Rs 1.20 Cr.
The company currently has active open charges totaling ₹4.00 Cr. The company has closed loans amounting to ₹3.63 M, as per Ministry of Corporate Affairs (MCA) records.
Pazhani Annamalai and Karpagam serve as directors at the Company.
- CIN/LLPIN
U74900TN2014PTC096930
- Company No.
096930
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2014
- Date of AGM
31 Oct 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Aura Biotechnologies Private Limited offer?
Aura Biotechnologies Private Limited offers a wide range of products and services, including Corona Test Kit, RNA Extraction Kit, Laboratory & Lab Equipment, Laboratory Stands, Pharma Ingredients & Raw Materials, Anti Infective API, Fertilizers and Soil Additives, Bio Fertilizers, Medical Laboratory Instruments, Pathology Lab Equipments.
Who are the key members and board of directors at Aura Biotechnologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pazhani Annamalai  | Director | 13-Aug-2014 | Current |
| Karpagam | Director | 13-Aug-2014 | Current |
Financial Performance of Aura Biotechnologies.
Aura Biotechnologies Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 67.09% decrease. The company also saw a substantial fall in profitability, with a 49.84% decrease in profit. The company's net worth Soared by an impressive increase of 19.89%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aura Biotechnologies?
In 2023, Aura Biotechnologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Jul 2023 | ₹2.00 Cr | Open |
Others Creation Date: 02 Jul 2022 | ₹2.00 Cr | Open |
Indian Overseas Bank Creation Date: 14 Sep 2015 | ₹3.63 M | Satisfied |
How Many Employees Work at Aura Biotechnologies?
Aura Biotechnologies has a workforce of 42 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aura Biotechnologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aura Biotechnologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
